{
  "name" : "twin.sci-hub.se_6551_8b5249b860c28db65890fb6102d3e59d_huang2017.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "Design and Functionalization of the NIR-Responsive Photothermal Semiconductor Nanomaterials for Cancer Theranostics",
    "authors" : [ "Xiaojuan Huang", "Wenlong Zhang", "Guoqiang Guan", "Guosheng Song", "Rujia Zou", "Junqing Hu" ],
    "emails" : [ "Fe3O4@Cu2xS", "Cu9S5@mSiO2," ],
    "sections" : [ {
      "heading" : "Design and Functionalization of the NIR-Responsive Photothermal Semiconductor Nanomaterials for Cancer Theranostics",
      "text" : ""
    }, {
      "heading" : "Xiaojuan Huang,† Wenlong Zhang,† Guoqiang Guan,† Guosheng Song,‡ Rujia Zou,*,† and Junqing Hu*,†",
      "text" : "†State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, Donghua University, Shanghai 201620, China ‡Department of Radiology, School of Medicine, Stanford University, Stanford, California 94305, United States\nCONSPECTUS: Despite the development of medical technology, cancer still remains a great threat to the survival of people all over the world. Photothermal therapy (PTT) is a minimally invasive method for selective photothermal ablation of cancer cells without damages to normal cells. Recently, copper chalcogenide semiconductors have emerged as a promising photothermal agent attributed to strong absorbance in the near-infrared (NIR) region and high photothermal conversion efficiency. An earlier study witnessed a rapid increase in their development for cancer therapy, including CuS, Cu2−xSe and CuTe nanocrystals. However, a barrier is that the minimum laser power intensity for effective PTT is still significantly higher than the conservative limit for human skin exposure. Improving the photothermal conversion efficiency and reducing the laser power density has become a direction for the development of PTT. Furthermore, in an effort to improve the therapeutic efficacy, many multimode therapeutic nanostuctures have been formulated by integrating the photothermal agents with antitumor drugs, photosensitizers, or radiosensitizers, resulting in a synergistic effect. Various functional materials also have been absorbed, attached, encapsulated, or coated on the photothermal nanostructures, including fluorescence, computed tomography, magnetic resonance imaging, realizing cancer diagnosis, tumor location, site-specific therapy, and evaluation of therapeutic responses via incorporation of diagnosis and treatment. In this Account, we present an overview of the NIR-responsive photothermal semiconductor nanomaterials for cancer theranostics with a focus on their design and functionalization based on our own work. Our group has developed a series of chalcogenides with greatly improved NIR photoabsorption as photothermal agents, allowing laser exposure within regulatory limits. We also investigated the photothermal bioapplications of hypotoxic oxides including WO3−x, MoO3−x, and RuO2, expanding their applications into a new field of photothermal materials. Furthermore, considering a much more enhanced therapeutic effect of multifunctional nanoagents, our group elaborately designed many nanocomposites, such as core−shell nanoparticles of Fe3O4@Cu2−xS and Cu9S5@mSiO2, based on the integration of photothermal agents with contrast agents or other anticancer medicines, achieving cancer theranostic and synergistic treatment. Ternary compound nanocrystals were also prepared with synthetic simplicity for multimodal imaging-guided therapy for cancer. This Account summarizes our past work, including the design and concept, synthesis, and characterization for in vitro and in vivo applications. Then, we analyzed the tendencies of the NIR-responsive photothermal semiconductor nanomaterials for clinical applications, highlighting their prospects and challenges. We believe that the photothermal technology from the NIR-responsive photothermal semiconductor nanomaterials would promote cancer theranostics to result in giant strides forward in the future."
    }, {
      "heading" : "1. INTRODUCTION",
      "text" : "Cancer is a serious disease that challenges the survival of people across the world. As indicated by the American Cancer Society, there are 1,688,780 new cancer cases and 600,920 cancer deaths projected to occur in the United States only in 2017, and it is estimated that the number of new cancer cases increase approximately 70% within the next two decades from 14 million in 2012 worldwide.1,2 Therefore, cancer treatment lies at the forefront of all human concern. Traditional methods for cancer treatment mainly include chemotherapy, radiotherapy (RT), and surgery. However, these treatments have high potential for collateral damages to healthy cells and tissues because of their nonspecificity and excessive radiation.\nFurthermore, multidrug resistance and cancer metastasis of patients during the treatment period are hard to avoid. As a result, the final therapeutic effects are not sufficient. Exploring an alternative or supplementary approach with both precise tumor localization and effective destruction is imperative. Photothermal therapy (PTT), as a method of physiotherapy,\nhas obtained immense popularity. It is where a photothermal agent is employed to absorb light-energy and then transform it to heat at the tumor site, thereby killing cancer cells via hyperthermia (40−45 °C) or thermal ablation (>45 °C),3\nReceived: June 12, 2017 Published: October 3, 2017\nArticle\npubs.acs.org/accounts\n© 2017 American Chemical Society 2529 DOI: 10.1021/acs.accounts.7b00294 Acc. Chem. Res. 2017, 50, 2529−2538\nCite This: Acc. Chem. Res. 2017, 50, 2529-2538\nwhich possesses advantages of high selectivity, minimal invasiveness, and no systemic effects. The effectiveness of PTT relies heavily on the photothermal agent. Primarily, ideal photothermal agents for PTT should have strong optical absorption, especially in the near-infrared (NIR) region (700− 1300 nm),4,5 due to the fact that water and blood cells have little absorption to NIR light, allowing deep tissue penetration of light to stimulate the optical-sensitive nanoparticles and minimize the damage in the surrounding healthy tissue.6 So far, a wide range of NIR-responsive photothermal agents have been explored covering noble metal nanostructures,7,8 carbon-based\nnanomaterials,9,10 organic dyes and polymers,11,12 and semiconductor nanomaterials.3,13,14\nAmong them, NIR-responsive semiconductor photothermal nanomaterials of metal oxides15,16 and chalcogenides,3,17,18 as a new type of photothermal agent, have made tremendous progress in recent years and show promising prospects dedicated to their unique features. First, the semiconductor photothermal nanomaterials hold facile synthesis and extremely low cost. Literature reports that the price of making 1 mol of CuS is US $330, and 1 mol of Au costs US $52,200.3 Second, they are not vulnerable to photobleaching and photodegradation like organic nanomaterials. Furthermore, because\nDOI: 10.1021/acs.accounts.7b00294 Acc. Chem. Res. 2017, 50, 2529−2538\n2530\nof the localized surface plasmon resonance (LSPR) in substoichiometric compounds, these photothermal semiconductor nanomaterials exhibit fine-tune absorption spectrum and large extinction coefficients in the NIR region. During the past several years, enormous efforts have been devoted to the photothermal performance and biomedical applications of the NIR-responsive photothermal semiconductor nanomaterials by our group, and some accomplishments have been achieved. We investigated the photothermal performance of various chalcogenides, including copper sulfides, bismuth sulfide, and tin sulfide, originally developed W18O49 and MoO3−x as PTT agents, and designed a variety of multifunctional nanoplatforms for cancer theranostics, like the Cu2−xS@SiO2 and Fe3O4@Cu2−xS core−shell nanocomposites, and ternary Cu3BiS3 nanocrystals, as shown in Figure 1. Therefore, in this Account we present a simple overview of the NIR-responsive photothermal semiconductor nanomaterials for cancer theranostics with a focus on their design and functionalization from three sections according to our own work, aiming to briefly demonstrate our design and concept, summarize some of our past works, and analyze tendencies regarding the NIR-responsive photothermal semiconductor nanomaterials for clinical applications."
    }, {
      "heading" : "2. CHALCOGENIDES",
      "text" : "Chalcogenides, as a typical class of semiconductor nanomaterials, draw significant attention for their applications in printed electronics, photovoltaic semiconductors, and solar cells in terms of their optical and electrical properties. Recently, ascribed to the copper vacancies, substoichiometric copper\nchalcogenides (Cu2−xX) prove to be an owner for LSPR, where the increased free carriers in Cu2−xX undergo a resonant interaction with the oscillating electromagnetic field of driving light.19 Taking Cu2−xS for instance, the carrier concentration reaches ∼1021 cm−3, corresponding to an LSPR frequency in the NIR region.20 That is to say, Cu2−xS demonstrates a strong NIR absorption from an optical standpoint, resulting in its emergence as a promising photothermal agent the same as Cu2−xSe and Cu2−xTe. An earlier study witnessed a rapid increase in their development for cancer therapy, including CuS,3 Cu2−xSe,\n13 and CuTe nanocrystals (NCs).21 They possess simple synthesis, low cost, and hypotoxicity. However, it is a barrier that the minimum laser power intensity used in these research studies for an efficient PTT effect (12 W/cm2, 808 nm laser) is still significantly higher than the conservative limit (∼0.33 W/cm2) for human skin exposure.22 To improve the photothermal conversion efficiency (PCE) and reduce the laser power density has become a direction for the development of PTT. On the basis of previous works, our group takes enormous effort to study the properties and applications of chalcogenides. We successfully developed CuS flower-like superstructures by a facile hydrothermal method14 in which the special flower-like structure composed of flakes makes it serve as excellent lasercavity mirrors, greatly improving the light-absorption ability in the NIR region as well as the photothermal effect.23,24 As shown in Figure 2b, the absorbance of our CuS superstructures at 980 nm shows a 2-fold promotion compared to CuS hexagonal nanoplates. With a 980 nm laser chosen as an excitation source, the temperature of the superstructure\nDOI: 10.1021/acs.accounts.7b00294 Acc. Chem. Res. 2017, 50, 2529−2538\n2531\ndispersion increased from ∼25 to ∼42 °C within 5 min, whereas the nanoplate dispersion showed a maximum temperature of ∼36 °C under the same conditions. Moreover, a low power density of 0.51 W/cm2 could stimulate a temperature increment of 10.7 °C in 5 min of the aqueous dispersion covered with a layer of chicken skin (thickness: ∼1 mm) as a biosimulation environment and demonstrate efficient photothermal ablation on tumors in vivo. The unique CuS flower-like superstructures exhibited a greatly improved photothermal efficiency, allowing an efficient PTT effect with a laser exposure below the regulatory limit (0.726 W/cm2 for 980 nm laser).22\nAlthough, there remains the problem that the CuS superstructures with relatively large size (∼1 μm) are unfavorable to be eliminated from living bodies. Serious underlying long-term toxicity and even vessel barrage could perhaps result. To solve this problem, our group again prepared smaller Cu9S5 plate-like NCs via a themolysis approach followed by surface modification.25 They were maintained with a small size of ∼70 nm × 13 nm, escaping from the drawbacks of large size, and are more suitable for biological applications. Furthermore, because of the LSPR property induced by copper deficiency, a dispersion of Cu9S5 (40 ppm) exhibited a large molar extinction coefficient of 1.2 × 109 cm−1 M−1 at 980 nm; the PCE reached as high as 25.7%, ensuring their application as an effective photothermal agent. In animal experiments, after the treatment with Cu9S5 and laser irradiation, tumors presented severe damage, including abundant karyorrhectic debris and considerable regions of karyolysis, as distinguished from hematoxylin and eosin (H&E)-stained images in Figure 3. Later, some other chalcogenide semiconductor nanomaterials were also successively constructed within our group, such as the\nCu7.2S4 NCs, 26 Cu7S4 hollow structures, 27 SnS nanosheets,28 and Bi2S3 nanoflowers. 29 Especially, the Cu7.2S4 NCs promote the PCE up to 56.7% irradiated by a 980 nm laser, noticeably higher than the previously reported photothermal nanomaterials, including Au nanorods (21%), Cu9S5 NCs (25.7%), and Cu2−xSe NCs (22%). Dual effect of the 3-dimensional flowerlike structure and lower band gap (Eg = 0.79 eV) also endows the Bi2S3 nanoflowers with a much more elevated photothermal performance compared with that of the Bi2S3 nanobelts. 29"
    }, {
      "heading" : "3. OXIDES",
      "text" : "Ensuring the safety of the photothermal nanomaterials is of great importance to their continued march toward clinical practice. Because of the impact of the crystalline phase, size, shape, surface-coating, and surface charge of the nanoparticles on their toxicity, our group has tried to apply the hydrophilic modification, SiO2-coating, and size-adjustment to improve the biosafety of the photothermal semiconductor nanomaterials. However, the toxicity of the chalcogenides as therapeutic agents still remains an issue. Researchers have proven that dysfunction in organisms can be induced by sulfide via an inhibition of cytochrome C oxidase and interference with almost 20 enzymes.30 From another aspect, chalcogenides are likely to release toxic metallic ion due to the relatively weaker chemical bonds between metallic ion and chalcogen (for example, D0Cu−S = 285 kJ/mol, D0Cu−O = 343 kJ/mol, 298 K).\n31,32 Therefore, we focused our attention on the stable and hypotoxic oxides. In 2013, our group prepared PEGylated W18O49 ultrafine nanowires (thickness of ∼0.9 nm, width of ∼4 nm, and lengths of ∼50 nm, as shown in Figure 4a and b) by a facile solvothermal pathway and studied their photothermal performance.15 Furthermore, they manifest a pretty low toxicity as\nDOI: 10.1021/acs.accounts.7b00294 Acc. Chem. Res. 2017, 50, 2529−2538\n2532\nanticipated. With 1 mg/mL of W18O49 solution administration, cell viability (>90%) was almost twice that of the CuS-treated cells (50%). In addition, the unusual oxygen deficiency reinvests the nanowires with LSPR character as well, thereby affording an increasing photoabsorption at a wavelength range from 510 to 1100 nm. Consequently, under 980 nm laser irradiation, the tumor region of the W18O49-treated mice showed a significant thermal signal, and its temperature increased to ∼50 °C rapidly, thus resulting in a hyperthermia-toxicity on cancer cells (Figure 4). This was the first report on the photothermal bioapplication of oxides, expanding their applications into a new field of photothermal treatment. In our other work, self-assembled WO3−x hierarchical nanostructures were developed as photothermal agents.33 A 915 nm laser was selected as the laser source for treatment; it avoids a negative influence on normal tissues induced by the strong photoabsorption of water at 980 nm and increases the tissue penetration depth compared with the 808 nm laser, which is meaningful for the PTT of cancer. At the same time, we also investigated the photothermal performance of molybdenum oxide. The hydrophilic MoO3−x nanoribbons were synthesized by a simple hydrothermal route.34 They were found to exhibit good photothermal performance similar to that of WO3−x and could effectively kill osteosarcoma U2OS cells through a photothermal conversion effect.34 However, it is worth noting that the oxidation reaction may dissatisfy the stability of the substoichiometric MoO3−x. When exposed to air, the prior absorption peak of MoO3−x would disappear, and the blue nanosheets gradually transform to white nanotubes.35 Some research studies have been done to improve its photostability, for example, using an ultrathin carbon layer coating (C/MoO2). 36\nOn the contrary, taking advantage of the instability, we put this work forward to design and synthesize MoOx-PEG nanosheets with a pH-dependent degradation property.16 The MoOx holds a constitutional formula of Hx(Mo V x)(Mo VI 1−x)Ox, which is prone to be oxidized to soluble MoVIO4 2− in the presence of oxygen in alkali environments, whereas conditions of neutral and acid are not beneficial to or even stop the\noxidation process. Thus, it is possible that MoOx nanosheets accessing organisms could degrade under normal physiological pH. Furthermore, just as predictably, the biodistribution of Mo shown in Figure 5a and b articulate that the nanomaterial retention in major organs and tissues decreases quickly over time and becomes extremely low, even in the liver and spleen. It ensured that the MoOx-PEG would not be retained for a long time in normal tissues and showed no further long-term toxicity to mice. On the other hand, the MoOx-PEG accumulating in tumor regions through the EPR effect were stable because of the acidic and lower oxygen level’s microenvironment (Figure 5c) and remained at a high level even 24 h postinjection. In this way, the MoOx-PEG nanosheets got in-suit PTT for tumors and efficiently degraded in vivo. Hydrous RuO2 (RuOx(OH)y) NCs were also studied by our group.37 They displayed good biocompatibility, photostability, low cytotoxicity, and high PCE (54.8%) due to the mixed valence of Ru3+/Ru4+. Moreover, cancer cells incubated with RuO2 could be efficiently thermally killed upon 808 nm laser irradiation. These results illustrate that RuO2 can be a novel photothermal agent for bioapplications as well."
    }, {
      "heading" : "4. MULTIFUNCTIONAL NANOPLATFORMS",
      "text" : ""
    }, {
      "heading" : "4.1. Synergistic Therapy",
      "text" : "NIR-responsive photothermal semiconductors have been demonstrated to be a promising nanomedicine in oncotherapy. However, the therapeutic effect is less than satisfactory in light of limitations generally found in each treatment approach. In attempts to improve the treatment performance, the PTT agents can be integrated with antitumor drugs, photosensitizers, and radiosensitizers. In this way, preloaded drugs, reactive oxygen species, and radioactivity could be released or generated in a controllable manner once exposed to a correspondingly appropriate extrinsic stimulus, thus leading to a synergistic therapeutic effect. Namely, apart from a combination of multimode treatments, the generated heat from PTT improves vessel permeability, blood circulation, and oxygen supply within tumors, favoring proceeding of drug-release, PDT, and RT. Furthermore, the enhanced hypoxic microenvironment led by\nDOI: 10.1021/acs.accounts.7b00294 Acc. Chem. Res. 2017, 50, 2529−2538\n2533\nPDT or RT endows the tumors with an increased heatsensitivity for PTT. Our group has integrated the photothermal agent with antitumor drug to rationally design the DOX-loaded Cu9S5@ mSiO2 (mesoporous silica) core−shell nanocomposites for the first time by a thermal decomposition approach and coating process.38 On one hand, SiO2 protects the core materials from the external environment and renders them hydrophilic, biocompatible, and chemically stable. On the other hand, the mesoporous shell with advantages of large specific surface volume and numerous pores makes it possible for drug or targeting delivery by loading functional molecules. Moreover, the drug delivery nanosystems show a pH-responsive release properties. At pH 4.8, the drug exhibited relatively higher release compared to that at pH 7.4, which is conducive to drug accumulation in an acidic tumor microenvironment rather than the neutral normal tissues. Figure 6 briefly exhibits the PTT\neffect for cells and nude mice bearing tumor model. It showed that the DOX-loaded Cu9S5@mSiO2−PEG nanocomposite could effectively kill cells in vitro and inhibit tumor growth under the NIR laser irradiation, and more importantly, the associated synergistic inhibition effect was the most remarkable. Moreover, the body-weight plots in Figure 6f indicated that all the mice’s weights were kept a normal level during the treatment period, further certifying the low toxicity of Cu9S5@ mSiO2 and its relevant treatment. Subsequently, various multifunctional DOX-loading nanocomposites such as CuS@mSiO2−PEG 39 and Cu2−xSe@ mSiO2−PEG40 have been synthesized. SN38 and Ce6 were also effectively loaded on the graphene analogues of MoOx− PEG nanosheets, realizing synergistic therapy of photothermal, photodynamic, and chemotherapy for cancer.16 The folic acidconjugated hollow mSiO2/CuS nanocomposites 41 were devel-\nDOI: 10.1021/acs.accounts.7b00294 Acc. Chem. Res. 2017, 50, 2529−2538\n2534\noped to compensate for the limitation of passive targeting and acquire the actively targetable therapeutic effect."
    }, {
      "heading" : "4.2. Diagnosis and Treatment",
      "text" : "From another perspective, theranostics based on the combination of photothermal nanomaterials and contrast agents is fascinating as their applications for cancer diagnosis, tumor location, site-specific therapy, and evaluation of therapeutic responses. It tends toward the movement of cancer therapy and has important clinical significance. On account of the noninvasion, high spatial resolution, and deep tissue penetration of magnetic resonance (MR) imaging, our group designed a theranostic nanostructure in which spherical-shaped Fe3O4 NCs were encapsulated into Cu2−xS thin shells forming ultrathin (<10 nm) Fe3O4@Cu2−xS core−shell nanocomposites.42 Figure 7a demonstrates the synthetic process of\nhomogeneous Fe3O4@Cu2−xS core−shell nanostructures. The obtained nanocomposites showed a T2-weighted MR property with image contrast gradually darkening along with increased Fe3+ concentration. Moreover, the relaxation rate (r2) and r2/ r1 ratio were calculated to be 141.4 mM−1 s−1 and 67, respectively, which are comparable to and even higher than those of commercial MR enhancers (Resovist, 86 mM−1 s−1, 4.3; Feridex, 152 mM−1 s−1, 5.6) with the same magnetic field intensity. These ascertain the possibility of the nanocomposites to be a potential T2-weighted MR contrast agent.43 In vivo MR imaging in Figure 7c−e indeed confirmed that a negative enhancement arose at the injection site of the nanomaterials. Meanwhile, the Fe3O4@Cu2−xS core−shell nanocomposite dispersion exhibited sedimentation behavior in a magnetic field and then showed a selective temperature increment upon\n980 nm laser irradiation. This illustrated that the magnetic property of the Fe3O4@Cu2−xS core−shell nanocomposites not only renders them to serve as a diagnostic reagent but also makes them available for a targetable PTT effect. Then, considering the commonly complicated synthetic processes and low productivities of nanotheranostics based on composites, we continued to construct the simple ternary Cu3BiS3 NCs as theranostic nanoplatforms.\n44 Because of the unusual defects as Cu2−xS and the large X-ray attenuation coefficient of bismuth (Bi: 5.74, I: 1.94 cm2/g at 100 keV), the concise Cu3BiS3 NCs exhibit strong NIR absorption and CT properties. Panels c and e in Figure 8 demonstrate the in vitro\nand in vivo CT imaging of the Cu3BiS3 NCs. Moreover, the NCs also owned NIR fluorescence emission with the 808 nm light excitation, thus enabling them to be used as a theragnosis platform for CT/fluorescence imaging-guided PTT. This research provides a novel path to explore multifunctional ternary compound nanomaterials, which skillfully bypass the tedious synthesis procedure of multifunctional nanocomposites and effectively results in multimodal imaging-guided combination therapy, promoting the development of multicomponent theranostic nanomaterials based on other semiconductors. In the meantime, on the basis of the upconversion fluorescence and computed tomography (CT) property of NaYF4, MR/CT characteristics of FeWO4, and strong NIR absorbance of polypyrrole (PPy), our group constructed the NaYF4@PPy 45 and FeWO4@PPy 46 core−shell nanostructures for cancer theranostics. Smaller CuCo2S4 NCs were prepared by a facile reflux method, achieving enhanced MR, PA, and photothermal performance simultaneously for their absorption\nDOI: 10.1021/acs.accounts.7b00294 Acc. Chem. Res. 2017, 50, 2529−2538\n2535\nin the NIR region and Co doping.47 We also prepared the multifunctional Na0.3WO3 nanorods attributed to the high Xray absorption coefficient (4.438 cm2/g at 100 keV) and the multivalence of tungsten.48 Multifunctional nanoplatforms offer intimate information about the tumors and guarantee the precise location and fault-free elimination of malignant tumors, providing great potential for cancer diagnosis and treatment."
    }, {
      "heading" : "5. CONCLUSIONS AND FUTURE PERSPECTIVE",
      "text" : "The study of NIR-responsive semiconductor nanomaterials is a rapidly advancing research field in which much research has been involved for their design and applications. In particular, relying on the strong NIR absorbance, semiconductor nanomaterials have been explored for photothermal ablation of cancer cells upon exposure to laser irradiation. These materials have been an attractive alternative to other photothermal agents considering their advantages of fine-tune optical absorption, low cost, good photostability, and higher PCE. Moreover, the abilities of specific targeting, tumor localization and diagnosis, and combination treatment can be endowed by integrating them with target moieties, contrast agents, and other therapeutic medicines, which enable the possibility of completely eradicating cancer cells. However, the development of nanobiotechnology based on the NIR-responsive photothermal semiconductor nanomaterials still lies at an early stage; there are many challenges remaining for their applications in the clinic. First and foremost, the toxicity of these nanomaterials remains a major concern. Systematic research should be performed on the relationship between toxicity and nanoparticle properties such as their composition, size, surface area, crystalline phase, and surface functionalization to develop the photothermal nanomaterials with very low or almost no toxicity. Meanwhile, it is an optional approach to seek a kind of photothermal semiconductor nanomaterial with significantly enhanced PCE, allowing for a lower dose during the treatment process. For further bioapplications, studies on pharmacokinetics and pharmacodynamics of these nanomaterials are imperative, including internalization and accumulation, biodistribution and clearance, therapy and immune response, and so forth. In addition, it is found that most of these current research studies are conducted on subcutaneous tumors, which accessible to be located and killed. The treatment of actually metastatic tumors remains an almost intractable problem, and future development should be directed toward it. Above all, if these bottlenecks are successfully overcome, the theranostics based on these semiconductor nanomaterials would make significant strides toward the clinic.\n■ AUTHOR INFORMATION Corresponding Authors\n*E-mail: rjzou@dhu.edu.cn. *E-mail: hu.junqing@dhu.edu.cn."
    }, {
      "heading" : "ORCID",
      "text" : "Rujia Zou: 0000-0001-5566-5091 Junqing Hu: 0000-0001-8422-7250"
    }, {
      "heading" : "Notes",
      "text" : "The authors declare no competing financial interest."
    }, {
      "heading" : "Biographies",
      "text" : "Xiaojuan Huang received her B.S. degree in chemical engineering and technology from East China University of Science and Technology (2012). She is currently pursuing her Ph.D. in the Department of Materials Science and Engineering at Donghua University under the supervision of Prof. Junqing Hu. Her current research interests are focusing on multifunctional nanomaterials and their bioapplications.\nWenlong Zhang received his M.S. degree in materials physics and chemistry from Shanghai University of Engineering Science (2015). He is currently pursuing his Ph.D. degree in Material Science at Donghua University under the supervision of Prof. Junqing Hu. His research interests focus on the design and synthesis of oxide nanomaterials for photothermal therapy.\nGuoqiang Guan received his B.S. degree in the Department of Materials Science and Engineering from Donghua University (2014). He is currently pursuing his Ph.D. degree in the Department of Materials Science and Engineering at Donghua University under the supervision of Prof. Junqing Hu. His current research interests are the synthesis of sulfide nanomaterials for photothermal therapy.\nGuosheng Song received his Ph.D. in the Department of Materials Science and Engineering at Donghua University under the supervision of Prof. Junqing Hu (2009−2014). He performed postdoctoral research within Prof. Zhuang Liu’s group at Soochow University (2014−2016) and currently continues his postdoctoral research within Prof. Jianghong Rao’s group at Stanford University. He majors in the synthesis and bioapplications of photothermal nanomaterials.\nRujia Zou received his M.S. degree in plasma physics and Ph.D. in Material Science from Donghua University in 2006 and 2009, respectively. At present, he is an associate professor at Donghua University. He has authored and coauthored more than 40 refereed journal publications and held over 10 patents. His current research interests focus on the properties of photothermal nanomaterials and their potential applications.\nJunqing Hu received his Ph.D. from the University of Science & Technology of China in 2000. From 2000 to 2008, he worked at the City University of Hong Kong and then the National Institute for Materials Science, Tsukuba, Japan. At present, he is a Full Professor at Donghua University, China. He has authored and coauthored more than 200 refereed journal publications and held over 50 patents. His current research interests focus on synthesis, property measurements, and applications of semiconductor nanomaterials.\n■ ACKNOWLEDGMENTS This work was financially supported by the National Natural Science Foundation of China (Grant Nos. 5167021113 and 21171035), the Shanghai Pujiang Program (Grant No. 16PJ1400200), the Program for Innovative Research Team in University of Ministry of Education of China (IRT_16R13), the DHU Distinguished Young Professor Program, and the Fundamental Research Funds for the Central Universities.\n■ REFERENCES (1) Torre, L. A.; Bray, F.; Siegel, R. L.; Ferlay, J.; Lortet-Tieulent, J.; Jemal, A. Global cancer statistics, 2012. Ca-Cancer J. Clin. 2015, 65, 87−108. (2) Siegel, R. L.; Miller, K. D.; Jemal, A. Cancer statistics, 2017. CaCancer J. Clin. 2017, 67, 7−30. (3) Li, Y. B.; Lu, W.; Huang, Q. A.; Huang, M. A.; Li, C.; Chen, W. Copper sulfide nanoparticles for photothermal ablation of tumor cells. Nanomedicine 2010, 5, 1161−1171.\nDOI: 10.1021/acs.accounts.7b00294 Acc. Chem. Res. 2017, 50, 2529−2538\n2536\n(4) Weissleder, R. A clearer vision for in vivo imaging. Nat. Biotechnol. 2001, 19, 316−317. (5) Jain, P. K.; Huang, X.; El-Sayed, I. H.; El-Sayed, M. A. Noble Metals on the Nanoscale: Optical and Photothermal Properties and Some Applications in Imaging, Sensing, Biology, and Medicine. Acc. Chem. Res. 2008, 41, 1578−1586. (6) Vogel, A.; Venugopalan, V. Mechanisms of Pulsed Laser Ablation of Biological Tissues. Chem. Rev. 2003, 103, 577−644. (7) Skrabalak, S. E.; Chen, J.; Au, L.; Lu, X.; Li, X.; Xia, Y. Gold Nanocages for Biomedical Applications. Adv. Mater. 2007, 19, 3177− 3184. (8) Chen, H.; Shao, L.; Ming, T.; Sun, Z.; Zhao, C.; Yang, B.; Wang, J. Understanding the photothermal conversion efficiency of gold nanocrystals. Small 2010, 6, 2272−2280. (9) Yang, K.; Zhang, S.; Zhang, G.; Sun, X.; Lee, S. T.; Liu, Z. Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett. 2010, 10, 3318−3323. (10) Yang, K.; Feng, L.; Shi, X.; Liu, Z. Nano-graphene in biomedicine: theranostic applications. Chem. Soc. Rev. 2013, 42, 530−547. (11) Sheng, Z.; Hu, D.; Zheng, M.; Zhao, P.; Liu, H.; Gao, D.; Gong, P.; Gao, G.; Zhang, P.; Ma, Y.; Cai, L. Smart Human Serum AlbuminIndocyanine Green Nanoparticles Generated by Programmed Assembly for Dual-Modal Imaging-Guided Cancer Synergistic Phototherapy. ACS Nano 2014, 8, 12310−12322. (12) Yang, K.; Xu, H.; Cheng, L.; Sun, C.; Wang, J.; Liu, Z. In vitro and in vivo near-infrared photothermal therapy of cancer using polypyrrole organic nanoparticles. Adv. Mater. 2012, 24, 5586−5592. (13) Hessel, C. M.; Pattani, V. P.; Rasch, M.; Panthani, M. G.; Koo, B.; Tunnell, J. W.; Korgel, B. A. Copper Selenide Nanocrystals for Photothermal Therapy. Nano Lett. 2011, 11, 2560−2566. (14) Tian, Q.; Tang, M.; Sun, Y.; Zou, R.; Chen, Z.; Zhu, M.; Yang, S.; Wang, J.; Wang, J.; Hu, J. Hydrophilic Flower-Like CuS Superstructures as an Efficient 980 nm Laser-Driven Photothermal Agent for Ablation of Cancer Cells. Adv. Mater. 2011, 23, 3542−3547. (15) Chen, Z.; Wang, Q.; Wang, H.; Zhang, L.; Song, G.; Song, L.; Hu, J.; Wang, H.; Liu, J.; Zhu, M.; Zhao, D. Ultrathin PEGylated W18O49 Nanowires as a New 980 nm-Laser-Driven Photothermal Agent for Efficient Ablation of Cancer Cells In Vivo. Adv. Mater. 2013, 25, 2095−2100. (16) Song, G.; Hao, J.; Liang, C.; Liu, T.; Gao, M.; Cheng, L.; Hu, J.; Liu, Z. Degradable Molybdenum Oxide Nanosheets with Rapid Clearance and Efficient Tumor Homing Capabilities as a Therapeutic Nanoplatform. Angew. Chem., Int. Ed. 2016, 55, 2122−2126. (17) Cheng, L.; Liu, J.; Gu, X.; Gong, H.; Shi, X.; Liu, T.; Wang, C.; Wang, X.; Liu, G.; Xing, H.; Bu, W.; Sun, B.; Liu, Z. PEGylated WS2 Nanosheets as a Multifunctional Theranostic Agent for in vivo DualModal CT/Photoacoustic Imaging Guided Photothermal Therapy. Adv. Mater. 2014, 26, 1886−1893. (18) Zhang, X.-D.; Chen, J.; Min, Y.; Park, G. B.; Shen, X.; Song, S.S.; Sun, Y.-M.; Wang, H.; Long, W.; Xie, J.; Gao, K.; Zhang, L.; Fan, S.; Fan, F.; Jeong, U. Metabolizable Bi2Se3 Nanoplates: Biodistribution, Toxicity, and Uses for Cancer Radiation Therapy and Imaging. Adv. Funct. Mater. 2014, 24, 1718−1729. (19) Zhao, Y.; Pan, H.; Lou, Y.; Qiu, X.; Zhu, J.; Burda, C. Plasmonic Cu2−xS Nanocrystals: Optical and Structural Properties of CopperDeficient Copper(I) Sulfides. J. Am. Chem. Soc. 2009, 131, 4253− 4261. (20) Luther, J. M.; Jain, P. K.; Ewers, T.; Alivisatos, A. P. Localized surface plasmon resonances arising from free carriers in doped quantum dots. Nat. Mater. 2011, 10, 361−366. (21) Li, W.; Zamani, R.; Rivera Gil, P.; Pelaz, B.; Ibañ́ez, M.; Cadavid, D.; Shavel, A.; Alvarez-Puebla, R. A.; Parak, W. J.; Arbiol, J.; Cabot, A. CuTe Nanocrystals: Shape and Size Control, Plasmonic Properties, and Use as SERS Probes and Photothermal Agents. J. Am. Chem. Soc. 2013, 135, 7098−7101. (22) Robinson, J. T.; Welsher, K.; Tabakman, S. M.; Sherlock, S. P.; Wang, H.; Luong, R.; Dai, H. High Performance In Vivo Near-IR (> 1\nmu m) Imaging and Photothermal Cancer Therapy with Carbon Nanotubes. Nano Res. 2010, 3, 779−793. (23) Zhang, F.; Wan, Y.; Yu, T.; Zhang, F.; Shi, Y.; Xie, S.; Li, Y.; Xu, L.; Tu, B.; Zhao, D. Uniform Nanostructured Arrays of Sodium RareEarth Fluorides for Highly Efficient Multicolor Upconversion Luminescence. Angew. Chem., Int. Ed. 2007, 46, 7976−7979. (24) Nishimura, S.; Abrams, N.; Lewis, B. A.; Halaoui, L. I.; Mallouk, T. E.; Benkstein, K. D.; Lagemaat, J. v. d.; Frank, A. J. Standing Wave Enhancement of Red Absorbance and Photocurrent in Dye-Sensitized Titanium Dioxide Photoelectrodes Coupled to Photonic Crystals. J. Am. Chem. Soc. 2003, 125, 6306−6310. (25) Tian, Q.; Jiang, F.; Zou, R.; Liu, Q.; Chen, Z.; Zhu, M.; Yang, S.; Wang, J.; Wang, J.; Hu, J. Hydrophilic Cu9S5 Nanocrystals: A Photothermal Agent with a 25.7% Heat Conversion Efficiency for Photothermal Ablation of Cancer Cells in Vivo. ACS Nano 2011, 5, 9761−9771. (26) Li, B.; Wang, Q.; Zou, R.; Liu, X.; Xu, K.; Li, W.; Hu, J. Cu7.2S4 nanocrystals: a novel photothermal agent with a 56.7% photothermal conversion efficiency for photothermal therapy of cancer cells. Nanoscale 2014, 6, 3274−3282. (27) Song, G.; Han, L.; Zou, W.; Xiao, Z.; Huang, X.; Qin, Z.; Zou, R.; Hu, J. A Novel Photothermal Nanocrystals of Cu7S4 Hollow Structurefor Efficient Ablation of Cancer Cells. Nano-Micro Lett. 2014, 6, 169−177. (28) Ren, Q.; Li, B.; Peng, Z.; He, G.; Zhang, W.; Guan, G.; Huang, X.; Xiao, Z.; Liao, L.; Pan, Y.; Yang, X.; Zou, R.; Hu, J. SnS nanosheets for efficient photothermal therapy. New J. Chem. 2016, 40, 4464− 4467. (29) Xiao, Z. Y.; Xu, C. T.; Jiang, X. H.; Zhang, W. L.; Peng, Y. X.; Zou, R. J.; Huang, X. J.; Liu, Q.; Qin, Z. Y.; Hu, J. Q. Hydrophilic bismuth sulfur nanoflower superstructures with an improved photothermal efficiency for ablation of cancer cells. Nano Res. 2016, 9, 1934−1947. (30) Li, T.; Li, E.; Suo, Y.; Xu, Z.; Jia, Y.; Qin, J. G.; Chen, L.; Gu, Z. Energy metabolism and metabolomics response of Pacific white shrimp Litopenaeus vannamei to sulfide toxicity. Aquat. Toxicol. 2017, 183, 28−37. (31) Rodhe, Y.; Skoglund, S.; Odnevall Wallinder, I.; Potaćova,́ Z.; Möller, L. Copper-based nanoparticles induce high toxicity in leukemic HL60 cells. Toxicol. In Vitro 2015, 29, 1711−1719. (32) Weast, R. C. Handbook of chemistry and physics; Chemical Rubber Company: FL, 1982; pp 180−200. (33) Li, B.; Zhang, Y.; Zou, R.; Wang, Q.; Zhang, B.; An, L.; Yin, F.; Hua, Y.; Hu, J. Self-assembled WO3‑x hierarchical nanostructures for photothermal therapy with a 915 nm laser rather than the common 980 nm laser. Dalton Trans. 2014, 43, 6244−6250. (34) Song, G.; Shen, J.; Jiang, F.; Hu, R.; Li, W.; An, L.; Zou, R.; Chen, Z.; Qin, Z.; Hu, J. Hydrophilic molybdenum oxide nanomaterials with controlled morphology and strong plasmonic absorption for photothermal ablation of cancer cells. ACS Appl. Mater. Interfaces 2014, 6, 3915−3922. (35) Huang, Q.; Hu, S.; Zhuang, J.; Wang, X. MoO(3‑x)-based hybrids with tunable localized surface plasmon resonances: chemical oxidation driving transformation from ultrathin nanosheets to nanotubes. Chem. - Eur. J. 2012, 18, 15283−15287. (36) Yi, X.; Yang, K.; Liang, C.; Zhong, X. Y.; Ning, P.; Song, G. S.; Wang, D. L.; Ge, C. C.; Chen, C. Y.; Chai, Z. F.; Liu, Z. ImagingGuided Combined Photothermal and Radiotherapy to Treat Subcutaneous and Metastatic Tumors Using Iodine-131-Doped Copper Sulfide Nanoparticles. Adv. Funct. Mater. 2015, 25, 4689− 4699. (37) Xiao, Z.; Jiang, X.; Li, B.; Liu, X.; Huang, X.; Zhang, Y.; Ren, Q.; Luo, J.; Qin, Z.; Hu, J. Hydrous RuO2 nanoparticles as an efficient NIR-light induced photothermal agent for ablation of cancer cells in vitro and in vivo. Nanoscale 2015, 7, 11962−11970. (38) Song, G.; Wang, Q.; Wang, Y.; Lv, G.; Li, C.; Zou, R.; Chen, Z.; Qin, Z.; Huo, K.; Hu, R.; Hu, J. A Low-Toxic Multifunctional Nanoplatform Based on Cu9S5@mSiO2 Core-Shell Nanocomposites: Combining Photothermal- and Chemotherapies with Infrared Thermal\nDOI: 10.1021/acs.accounts.7b00294 Acc. Chem. Res. 2017, 50, 2529−2538\n2537\nImaging for Cancer Treatment. Adv. Funct. Mater. 2013, 23, 4281− 4292. (39) Liu, X.; Ren, Q.; Fu, F.; Zou, R.; Wang, Q.; Xin, G.; Xiao, Z.; Huang, X.; Liu, Q.; Hu, J. CuS@mSiO(2)-PEG core-shell nanoparticles as a NIR light responsive drug delivery nanoplatform for efficient chemo-photothermal therapy. Dalton Trans. 2015, 44, 10343−10351. (40) Liu, X.; Wang, Q.; Li, C.; Zou, R.; Li, B.; Song, G.; Xu, K.; Zheng, Y.; Hu, J. Cu2‑xSe@mSiO(2)-PEG core-shell nanoparticles: a low-toxic and efficient difunctional nanoplatform for chemo-photothermal therapy under near infrared light radiation with a safe power density. Nanoscale 2014, 6, 4361−4370. (41) Liu, X.; Fu, F.; Xu, K.; Zou, R.; Yang, J.; Wang, Q.; Liu, Q.; Xiao, Z.; Hu, J. Folic acid-conjugated hollow mesoporous silica/CuS nanocomposites as a difunctional nanoplatform for targeted chemophotothermal therapy of cancer cells. J. Mater. Chem. B 2014, 2, 5358− 5367. (42) Tian, Q.; Hu, J.; Zhu, Y.; Zou, R.; Chen, Z.; Yang, S.; Li, R.; Su, Q.; Han, Y.; Liu, X. Sub-10 nm Fe3O4@Cu2‑xS Core-Shell Nanoparticles for Dual-Modal Imaging and Photothermal Therapy. J. Am. Chem. Soc. 2013, 135, 8571−8577. (43) Bjornerud, A.; Johansson, L. O.; Ahlstrom, H. K. Renal T-2* perfusion using an iron oxide nanoparticle contrast agent - Influence of T-1 relaxation on the first-pass response. Magn. Reson. Med. 2002, 47, 298−304. (44) Li, B.; Ye, K.; Zhang, Y.; Qin, J.; Zou, R.; Xu, K.; Huang, X.; Xiao, Z.; Zhang, W.; Lu, X.; Hu, J. Photothermal Theragnosis Synergistic Therapy Based on Bimetal Sulphide Nanocrystals Rather Than Nanocomposites. Adv. Mater. 2015, 27, 1339−1345. (45) Huang, X.; Li, B.; Peng, C.; Song, G.; Peng, Y.; Xiao, Z.; Liu, X.; Yang, J.; Yu, L.; Hu, J. NaYF4:Yb/Er@PPy core-shell nanoplates: an imaging-guided multimodal platform for photothermal therapy of cancers. Nanoscale 2016, 8, 1040−1048. (46) Xiao, Z.; Peng, C.; Jiang, X.; Peng, Y.; Huang, X.; Guan, G.; Zhang, W.; Liu, X.; Qin, Z.; Hu, J. Polypyrrole-encapsulated iron tungstate nanocomposites: a versatile platform for multimodal tumor imaging and photothermal therapy. Nanoscale 2016, 8, 12917−12928. (47) Huang, X.; Deng, G.; Liao, L.; Zhang, W.; Guan, G.; Zhou, F.; Xiao, Z.; Zou, R.; Wang, Q.; Hu, J. CuCo2S4 nanocrystals: a new platform for multi-modal imaging guided photothermal therapy. Nanoscale 2017, 9, 2626−2632. (48) Zhang, Y.; Li, B.; Cao, Y.; Qin, J.; Peng, Z.; Xiao, Z.; Huang, X.; Zou, R.; Hu, J. Na0.3WO3 nanorods: a multifunctional agent for in vivo dual-model imaging and photothermal therapy of cancer cells. Dalton Trans. 2015, 44, 2771−2779.\nDOI: 10.1021/acs.accounts.7b00294 Acc. Chem. Res. 2017, 50, 2529−2538\n2538"
    } ],
    "references" : [ {
      "title" : "A clearer vision for in vivo imaging",
      "author" : [ "R. Weissleder" ],
      "venue" : "Nat. Biotechnol",
      "citeRegEx" : "Weissleder,? \\Q2001\\E",
      "shortCiteRegEx" : "Weissleder",
      "year" : 2001
    }, {
      "title" : "Mechanisms of Pulsed Laser Ablation of Biological Tissues",
      "author" : [ "A. Vogel", "V. Venugopalan" ],
      "venue" : "Chem. Rev. 2003,",
      "citeRegEx" : "Vogel and Venugopalan,? \\Q2003\\E",
      "shortCiteRegEx" : "Vogel and Venugopalan",
      "year" : 2003
    }, {
      "title" : "Copper Selenide Nanocrystals for Photothermal Therapy",
      "author" : [ "J.W. Tunnell", "B.A. Korgel" ],
      "venue" : "Nano Lett. 2011,",
      "citeRegEx" : "B. et al\\.,? \\Q2011\\E",
      "shortCiteRegEx" : "B. et al\\.",
      "year" : 2011
    }, {
      "title" : "SnS nanosheets for efficient photothermal therapy",
      "author" : [ "Z. Xiao", "L. Liao", "Y. Pan", "X. Yang", "R. Zou", "J. Hu" ],
      "venue" : "New J. Chem. 2016,",
      "citeRegEx" : "X. et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "X. et al\\.",
      "year" : 2016
    }, {
      "title" : "Copper-based nanoparticles induce high toxicity in leukemic HL60 cells",
      "author" : [ "L. Möller" ],
      "venue" : "Toxicol. In Vitro 2015,",
      "citeRegEx" : "Möller,? \\Q2015\\E",
      "shortCiteRegEx" : "Möller",
      "year" : 2015
    }, {
      "title" : "Handbook of chemistry and physics",
      "author" : [ "R.C. Weast" ],
      "venue" : "Chemical Rubber Company: FL,",
      "citeRegEx" : "Weast,? \\Q1982\\E",
      "shortCiteRegEx" : "Weast",
      "year" : 1982
    }, {
      "title" : "Self-assembled WO3‐x hierarchical nanostructures for photothermal therapy with a 915 nm laser rather than the common 980 nm laser",
      "author" : [ "Y. Hua", "J. Hu" ],
      "venue" : "Dalton Trans. 2014,",
      "citeRegEx" : "Hua and Hu,? \\Q2014\\E",
      "shortCiteRegEx" : "Hua and Hu",
      "year" : 2014
    }, {
      "title" : "Hydrous RuO2 nanoparticles as an efficient NIR-light induced photothermal agent for ablation of cancer cells in vitro and in vivo",
      "author" : [ "J. Luo", "Z. Qin", "J. Hu" ],
      "venue" : "Nanoscale 2015,",
      "citeRegEx" : "Luo et al\\.,? \\Q1970\\E",
      "shortCiteRegEx" : "Luo et al\\.",
      "year" : 1970
    }, {
      "title" : "Imaging for Cancer Treatment",
      "author" : [ "Q. Ren", "F. Fu", "R. Zou", "Q. Wang", "G. Xin", "Z. Xiao", "X. Huang", "Q. Liu", "J. Hu" ],
      "venue" : "Adv. Funct. Mater",
      "citeRegEx" : "X. et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "X. et al\\.",
      "year" : 2013
    }, {
      "title" : "Fe3O4@Cu2‐xS Core-Shell Nanoparticles for Dual-Modal Imaging and Photothermal Therapy",
      "author" : [ "A. Bjornerud", "L.O. Johansson", "H.K. Ahlstrom" ],
      "venue" : "J. Am. Chem. Soc",
      "citeRegEx" : "Bjornerud et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "Bjornerud et al\\.",
      "year" : 2013
    } ],
    "referenceMentions" : [ ],
    "year" : 2017,
    "abstractText" : "Semiconductor Nanomaterials for Cancer Theranostics Xiaojuan Huang,† Wenlong Zhang,† Guoqiang Guan,† Guosheng Song,‡ Rujia Zou,*,† and Junqing Hu*,† †State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, Donghua University, Shanghai 201620, China ‡Department of Radiology, School of Medicine, Stanford University, Stanford, California 94305, United States",
    "creator" : "Arbortext Advanced Print Publisher 10.0.1465/W Unicode"
  }
}